• National Cancer Institute
  • National Human Genome Research Institute

Timothy Ley, M.D., Advocates for Personalized Medicine in the Treatment of AML

You will need Adobe Flash Player 8 or later and JavaScript enabled to view this video.


Timothy Ley, M.D., Advocates for Personalized Medicine in the Treatment of AML (2:41)

Oncologist Dr. Timothy Ley talks about how repurposing of existing drugs based on better understanding of the genetic basis of acute myeloid leukemia (AML) can help patients receive personalized care.


 >> View All Videos